The First Affiliated Hospital Of Bengbu Medical University
Clinical trials sponsored by The First Affiliated Hospital Of Bengbu Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Social connection as medicine: a brain-training trial for gaming addiction Results expected Dec 2026 (estimated)
- Can chemotherapy harm the thyroid? a new study investigates Results expected Apr 2027 (estimated)
- Can a pill replace chemo for stomach cancer in the elderly? Results expected Aug 2027 (estimated)
- Can a blood vessel blocker stop Cancer-Related belly fluid? Results expected Sep 2027 (estimated)
- Can adding a Blood-Vessel blocker boost chemotherapy for Triple-Negative breast cancer? Results expected Sep 2027 (estimated)
-
New gene therapy aims to tame PKU in first human test
Disease control OngoingThis early-phase study tests a single IV dose of NGGT002 gene therapy in 15 adults with phenylketonuria (PKU), a genetic disorder that causes harmful buildup of phenylalanine. The main goal is to check safety over one year, with long-term follow-up for five years. Researchers wil…
Early phase 1 • Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a smartphone app help frail heart patients get stronger?
Disease control By invitation onlyThis study tests a new health management program for people with coronary heart disease who also have frailty (weakness, low energy). The program uses a mobile app to guide exercise and healthy habits, with support from a cardiac rehab center. Researchers will enroll 200 particip…
Sponsor: The First Affiliated Hospital of Bengbu Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC